LSV Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

LSV Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-165	Closed	-$11K	–	1126
2016 Q1	$11K	Hold	165	–	–	﹤0.01%	1019
2015 Q4	$11K	Hold	165	–	–	﹤0.01%	1001
2015 Q3	$13K	Hold	165	–	–	﹤0.01%	957
2015 Q2	$12K	Hold	165	–	–	﹤0.01%	940
2015 Q1	$14K	Hold	165	–	–	﹤0.01%	899
2014 Q4	$15K	Hold	165	–	–	﹤0.01%	917
2014 Q3	$16K	Hold	165	–	–	﹤0.01%	892
2014 Q2	$21K	Hold	165	–	–	﹤0.01%	858
2014 Q1	$28K	Hold	165	–	–	﹤0.01%	842
2013 Q4	$24K	Hold	165	–	–	﹤0.01%	869
2013 Q3	$27K	Hold	165	–	–	﹤0.01%	958
2013 Q2	$19K	Buy	+165	New	+$18.9K	﹤0.01%	867

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

SIM

Sigma Investment Management Portland, Oregon $125M AUM 4.75% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

LSV Asset Management's VBIV Position: Q2 2016 in Review

LSV Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2016, closing a stake of 165 shares — an estimated $11K sold.

LSV Asset Management first reported a position in VBIV in Q2 2013 and held it in 12 quarters. The position peaked at $28K in Q1 2014. 19 funds tracked by Wall St. Rank hold VBIV as of Q2 2016.

LSV Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2016 after selling out during the quarter.
LSV Asset Management sold 165 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2016, an estimated $11K.
LSV Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2013 and held it in 12 quarters.
LSV Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $28K in Q1 2014.
19 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2016.

Based on LSV Asset Management's 13F filing for Q2 2016, filed 5 Aug 2016.